since the blood is an unfavourable compartment for the microbes due to its 102 bacteriostatic and bactericidal components 1,13
The term microbiome describes the genetic material encoding the various microbial 10 populations that inhabit our body. Whilst colonisation of various body niches (e.g. the 11 gut) by dynamic communities of microorganisms is now universally accepted, the 12 existence of microbial populations in other "classically sterile" locations, including the 13 blood, is a relatively new concept. The presence of bacteria-specific DNA in the 14 blood has been reported in the literature for some time, yet the true origin of this is 15 still the subject of much deliberation. The aim of this study was to provide a 16 comprehensive description of the human blood microbiome using a range of 17 complementary molecular and classical microbiological techniques. DNA-level 18
analyses involved the amplification and sequencing of the 16S rDNA gene. level analyses were based upon the de novo assembly of unmapped mRNA reads. 20
Molecular studies were complemented by viability data from classical aerobic and 21
anaerobic microbial culture experiments. At the phylum level, the blood microbiome 22
was predominated by Proteobacteria, Actinobacteria, Firmicutes and Bacteroidetes. 23
The key phyla detected were consistent irrespective of molecular method (DNA vs 24 RNA), and consistent with the results of other published studies. In silico comparison 25 of our data with that of the Human Microbiome Project revealed that members of the 26 blood microbiome were most likely to have originated from the oral or skin 27 communities. To our surprise, aerobic and anaerobic cultures were positive in eight 28 of out the ten donor samples investigated, and we reflect upon their source. Our data 29 provide further evidence of a core blood microbiome, and provide insight into the 30 potential source of the bacterial DNA / RNA detected in the blood. Further, data 31 reveal the importance of robust experimental procedures, and identify areas for 32 future consideration. 33 34 35
Background 36 The term "microbiome" describes the genetic material encoding the various microbial 37 populations that inhabit our body. In contrast, the term "microbiota" refers to the 38 viable organisms that comprise these communities. Cell for cell, bacterial cells 39 outnumber our own cells by a factor of ten, and the bacterial microbiome encodes for 40 one hundred-fold more genes. The microbiome undertakes essential biological 41 processes and thus it is unsurprising that a number of disease states are associated 42
with changes in microbiome composition, termed "dysbiosis". Whilst the colonisation 43 of specific body sites in contact with the external environment (such as the 44 gastrointestinal tract, skin and vagina) by microorganisms is both well-described and 45
universally accepted 1 , the existence of microbial populations in other "classically 46
sterile" locations, including the blood, is a relatively new concept. 47
48
The presence of bacteria-specific DNA in the blood has been reported in the 49 literature for some time, yet the true origin of this is still the subject of much 50 deliberation. Mounting evidence supports the existence of a blood microbiome 51
(specifically, the presence of bacterial genetic material) in man [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] and various other 52 species including rodents, cats, chickens and cows [12] [13] [14] [15] as determined by 53 amplification and sequencing of the bacterial 16S rRNA gene, or via whole genome 54
sequencing. Such studies report the existence of bacteria-derived genetic material 55
(DNA) within the circulation, but do not provide evidence for the presence of viable 56 organisms. 57 58
Convention tells us that the blood is sterile in health, and bacteraemia, even at 1 -59 10 bacterial cells per millilitre whole blood, is potentially life threatening. Despite 60 this, several studies have presented evidence of bacteria or bacteria-like structures 61
within the circulation in the absence of overt disease. It should be noted however 62
that Martel and colleagues report that the bacteria-like particles often described 63 following a range of imaging techniques represent non-living membrane vesicles and 64 protein aggregates derived from the blood itself 16 . McLaughlin surveyed the blood of 65 25 healthy donors and observed the presence of pleomorphic bacteria using dark-66 field microscopy, electron microscopy, polymerase chain reaction and fluorescent in 67 situ hybridisation, in all samples analysed 17 . Further, Potgieter and colleagues 68
described the presence of blood-cell associated bacteria in a range of blood 69 preparations using electron microscopic techniques 8 . Significantly, Damgaard and 70 colleagues found viable (culturable) bacteria in 62% of blood donations from donors 71 with no overt disease 18 . This finding is plausible given that various daily activities 72
including chewing, tooth brushing and flossing result in the translocation of oral 73 bacteria into the bloodstream 19-22 however one would expect such organisms to be 74 rapidly targeted and removed with by the immune system in healthy individuals. Kell, 75 D and colleagues provide a detailed hypothesis for the existence of the blood 76 microbiome 4,8 and suggest that it is likely composed of organisms (or parts thereof) 77 that translocate to the circulation from their usual place of habitation (classical niches 78 such as the gastrointestinal tract, oral cavity, skin, vagina) -a process termed 79 atopobiosis. They further describe how this could occur via well-described 80 physiological processes including dendritic cells processes, via micro-fold cells, and 81 in disease, via dysfunctional epithelial junctions. This explanation is supported by 82 studies demonstrating a correlation between gut microbiota dysbiosis and altered 83 microbial signatures detected in the blood 23-25 , suggesting that the observed 84 disease-associated blood microbiota is a consequence of increased bacterial 85 translocation across the gut barrier. Furthermore, characterisation of the microbial 86 populations in the coronary artery tissues by Lehtiniemi and colleagues 26 identified 87 known members of the oral microbiota, suggesting that bacteria had translocated 88 from the oral cavities into the bloodstream, potentially as a result of damage caused 89 by tooth brushing or by leakage across the mucosal surfaces. 90 91
Various disease states are associated with blood microbiome dysbiosis 2,6,24,25,27 , 92 and these changes are likely reflective of dysbiosis at a distant site(s) with well-93 characterised microbial communities, and the result of subsequent translocation.
94
Limited evidence also suggests that these changes may be disease-specific; 95
Alzheimer's disease for example, has been associated with the detection of mostly 96
coccus microbes, whilst Parkinson's disease has been associated with both coccus 97 and bacillus bacteria 8 . Such changes are of significant scientific and medical interest 98
as they offer opportunities for biomarker and therapeutic target development 25, 27 . 99 100
Due to the long-held belief that the bloodstream of healthy individuals is sterile and
Materials and Methods 136 137
Donor Samples 138
Atopic asthmatic individuals (n=5) with physician-diagnosed house dust mite allergy, 139
and gender and age-matched healthy control subjects (n=5) were recruited to the 140 study via SeraLabs Limited in accordance with the following criteria (Table 1) Amplicons resulting from triplicate reactions were combined and purified using the 167
MinElute PCR purification kit (Qiagen) prior to a further 7 cycles of PCR using 168
AccuPrime Pfx SuperMix and a pair of V4 oligonucleotide primers we developed to 169 incorporate the Illumina XT adapter in preparation for sequencing ( Table 2) . Cycling 170 parameters were as follows; initial denaturation for 2 minutes at 95 o C followed by 7 171 cycles of; denaturation (15 seconds at 95 o C), annealing (30 seconds at 55 o C), and 172 extension (25 seconds at 68 o C), and a final extension at 68 o C for 10 minutes. PCR 173 products were purified using the AMPure XP magnetic beads (Agencourt) at a ratio 174 of 0.8 beads to sample (v/v), eluted in 20μl molecular biology grade water, and 175 quantified using the Qubit 3.0 high-sensitivity DNA kit. Amplicons were barcoded 176
using the Nextera DNA library kit, multiplexed, and sequenced using the Ilumina 177
MiSeq system with a 250bp paired-end read metric. Bioinformatic analysis was 178 performed using QIIME 30 implemented as part of the Nephele 16S paired-end QIIME 179 pipeline using closed reference clustering against the SILVA database 31 at a 180 sequence identity of 99%. All other parameters remained as default. 181 182 
Results and Discussion

228
Donor Characteristics 229
The donor population were all female and all "never smokers". The asthmatic 230 population were 39.6 years in age (range 19 -52) with a mean body mass index of 231 24.4 (range 21.5 -27.8) and all had physician-diagnosed atopic asthma resulting 232 from house dust mite allergy. The control population were 39.4 years in age (range 233 23 -49) with a mean body mass index of 24.3 (range 21.0 -26.4) and were 234 disease-free. There were no statistically significant differences in age (P = 0.98) or 235 BMI (P = 0.93) between the two groups ( 
239
DNA-level Circulating Microbiome -Community Structure 240
The presence of bacterial DNA within the blood of our study cohort was evaluated by 241 amplification and sequencing of the 16S RNA gene variable region 4. A negative 242
experimental control sample mirrored our study samples through the entire 243 experimental procedure upstream of venepuncture including; PCR, bead-based 244 purification, agarose gel electrophoresis, XT-tagging, library preparation and 245
sequencing. Despite this control reaction being PCR-negative, it was nevertheless 246 submitted for sequencing. Using QIIME 30 implemented as part of Nephele, a total of 247 243, 853 sequencing reads from the amplified V4 region passed quality assessment 248
(mean = 24,385 reads per sample; range = 10, 742 -35, 701 reads). The results of 249 our taxonomic classification are shown in (Figure 2 A-D) at the phylum and genus 250 levels. 251 252
Our negative control reaction generated a small number of reads that were identified 253 as the following genera; Halomonas (6 reads), Corynebacterium (64), 254
Staphylococcus ( At the phylum level, the blood microbiome was predominated by Proteobacteria 259
(88% of all bacterial DNA in the control population, and 80.9% in the asthmatic 260 population) followed by Actinobacteria (control = 7.8%, asthmatic = 7.1%), 261
Firmicutes (control = 3.5%, asthmatic = 9.2%) and Bacteroidetes (control = 0.1%, 262 asthmatic = 2.2%). These findings mirror previous studies 2,7,25,28 and further support 263 the notion of a core blood microbiome predominated by four key phyla.
265
At the genus level, our blood samples were predominated by the genus 266
Achromobacter 38 which accounted for 51.1% and 45.3% of the total bacterial DNA 267 detected in the control and asthma donors respectively. To a lesser extent, the blood 268 samples also comprised members of the Pseudomonas (12.8%, 7.5%) 7,9,18 , 269 Serratia* (0.9%, 11.6%) 39 , Sphingomonas (3.8%, 5.1%) 7,25 , Staphylococcus (5.5%, 270
2.8%) 7,18,40,41 , Corynebacterium (3.2%, 5.5%) 7,9 , and Acinetobacter (3.7%, 2.8%) 7 271 genera. The genus Serratia was excluded from further analysis as the study samples 272
presented with less reads than did the corresponding negative control reaction and 273
thus it was considered a contaminant.
275
Whilst all genera found have been previously described in the blood (see 276 references), the predominance of Achromobacter, which is not classically associated 277
with the blood microbiome, warrants further consideration. Indeed, Achromobacter 278
has been detected abundantly in the lower respiratory tract of healthy mice 42 , 279
humans (HPM airway dataset), and in various respiratory conditions 43, 44 . 280
Furthermore, no Achromobacter was detected in our control reactions suggesting 281 that its presence is not the result of experimental contamination. 282 283
Although differential composition of the blood microbiome in response to pathology 284
was not the main focus of this study, we performed principal coordinates analysis 285
and despite the relatively small sample set, this revealed good separation between 286 the two treatment groups based upon their microbiome profile, suggesting that the 287 blood microbiome community was altered in the asthmatic subjects (Figure 3) . (blue) and asthmatic (red) blood microbiome profiles. Each dot represents an 304
individual sample, and the microbiome of samples that appear more closely together 305 are more similar. 306 307 308
DNA-level Circulating Microbiome -Likely Origins 309
In accordance with our hypothesis that the blood microbiome exists as a 310
consequence of bacterial translocation from other microbiome niches within the 311 body, we compared the data generated herein with gastrointestinal tract, oral cavity, 312
and skin data made available by the Human Microbiome Project (HMP). In each 313 case, the HMP data and our own were combined, weighted UniFrac distances 314 calculated, and a principal coordinates analysis performed. Figure 4 demonstrates 315
that the blood microbiome of our control and asthmatic donors clustered more 316 closely in PCoA space with the oral cavity and skin HMP data, than it did with the 317 gastrointestinal tract HMP data. This suggests that the blood microbiome community 318
is perhaps more likely to result from the translocation of organisms from the oral 319 cavity and skin, than from organisms that colonise the gastrointestinal tract. 320 321
Various daily activities including chewing, tooth brushing and flossing have been 322
shown to result in the translocation of bacteria from the oral cavity into the 323 bloodstream [19] [20] [21] [22] . Further, the skin has a distinct microbial community and is 324 susceptible to injury, and thus represents a large surface area through which such 325 organisms may translocate to the bloodstream. It is important here to consider 326 sources of contamination; venepuncture, the process through which the majority of 327 blood samples are obtained, is recognised as a cause of transient bacteraemia 45 , 328 and despite the use of preventative measures such as alcohol cleansing of the skin 329 prior to breaking the surface, there remains the possibility that organisms entered the 330 sample from the skin via this route. 331 332
One important, but often overlooked limitation of DNA-based microbiome 333
characterisation is that DNA persists post-mortem, even in the presence of harsh 334 environmental conditions. From such analyses it is therefore impossible to confirm 335
whether an organism is present and viable, is present but computational efficiency and was therefore used for transcriptome assembly. The 370 transcriptome comprised 2050 candidate "non-human genes" with a mean GC 371 content of 53%. Ten-percent of these genes were greater than 517bp, and over half 372
were at least 263bp. Taxonomic identification of each assembled feature was 373 determined using Kraken 36 and this revealed that 729 of the 2050 features were of 374 bacterial origin, and 7 features were from archaea (Figure 5) .
376
At the phylum level, the whole transcriptome data was predominated by assembled 377
Proteobacteria sequences (379 sequences, 52%), followed by Firmicutes (143 Bacteroidetes (0.05%, 0.008%) present to a much lesser extent. These findings 384 support our DNA-level phylum data and mirror previous studies 2,7,25,28 .
386
At the genus level, the whole transcriptome data was predominated by the genera 387
Paenibacillus (17.8%, 44.6%; Control, Asthma reads) 48 , Escherichia (11.8%, 13.1%) 388 7, 9, 40, 49 , Acinetobacter (0.7%, 0.4%) 7 , Pseudomonas (0.8%, 0.1%) 7, 9, 18, 50 and 389
Propionibacterium (0.5%, 0.2%) 9, 18, 41, 50 . With the exception of Paenibacillus, all 390 genera detected via de novo transcriptome assembly were also present in our DNA-391 level data and all genera found have been previously described in the blood (see 392 references). The fact that Paenibacillus was present within our RNA-level analyses 393 yet absent from our DNA-level data led us to consider whether it could have been 394
introduced as a contaminant during the RNA extraction, library preparation or 395 sequencing procedures. Given that negative control reactions are not routinely 396
conducted for RNA-seq type applications, we were unable to experimentally confirm 397
this. However, we did identify from the literature that this genus has been reported as 398 a common reagent and laboratory contaminant, albeit at the DNA level 51 . 399
Nevertheless there appeared to be little consistency in its presence within our 400 sample set (mean % of reads 39.5 ± 40.3%) and we noted a difference in abundance 401 The presence of viable, proliferating bacteria in the blood was assessed using 419 growth culture assays as previously described. To our surprise, bacterial cultures 420
were positive for the majority of the blood samples assayed (8 out of 10 samples; 4 421
control blood samples and 4 asthma blood samples), whilst all negative control 422
plates had no growth as expected. In all instances, bacterial growth was monoculture 423 on microscopy and thus 16S colony PCR (amplifying the entire 16S gene) and 424
Sanger sequencing was conducted on a three independent colonies per plate for 425 identification purposes. 426 427
Bacteria were identified using Sanger sequencing following classification with 428
Kraken, and included the following genera; Staphylococcus (49 sequences), 429
Micrococcus (12), Kocuria (6), Corynebacterium (6) and Propionibacterium (1) 430 (Figure 6) . These genera belong to the phyla Actinobacteria (Corynebacterium, 431
Kocuria, Micrococcus) and Firmicutes (Staphylococcus) and were all represented in 432 our 16S DNA level data (Figure 4) and detected within our RNA data. Individual 433 sample data is presented in ( Due to the long-held belief that the bloodstream of healthy individuals is sterile and 440 since the blood is an unfavourable compartment for the microbes due to its 441 bacteriostatic and bactericidal components; here we consider the likely source of 442 these viable organisms. The skin microbiome is dominated by members of the 443 genera Corynebacterium, Micrococcus, Staphylococcus, and Propionibacterium, 444
the proportions of which vary markedly between individuals 52 . Furthermore, 445
several studies report the presence of the genus Kocuria on the skin of humans 446
and other mammals [53] [54] [55] . We therefore suggest that the organisms detected 447 through our microbial culture experiments most likely originate from the skin. 448
Whilst transient bacteraemia due to a breach of the skin barrier is an accepted 449 occurrence, one would expect such organisms to be rapidly targeted and removed 450 by the immune system. We therefore suggest that the viable organisms detected 451 are the result of venepuncture contamination whereby organisms from the skin are 452 drawn into the vacutainer, contaminating the sample. refer to the number of features classified as such (e.g. 49 colonies were identified as 460
Staphylococcus). In all cases, the lowest taxonomic rank is indicated. D -domain, P 461 -phylum, F -family, G -genus, S -species. 462 463 464 This study utilised a range of molecular and classical microbiology approaches to 478 characterise the human blood microbiome in unparalleled detail. Our DNA and RNA-479
based studies revealed a diverse community of bacterial, the main members of 480 which having been described in a range of other studies and therefore providing 481 further evidence of a core blood microbiome. Although disease associated changes 482
in the blood microbiome were not the focus of this study, the fact we identified such 483
changes is encouraging and supports efforts to identify circulating microbiome 484 signatures indicative of disease. 485 486
To our surprise, culture based experiments revealed viable bacteria present in eight 487 of our ten study samples. Whilst we attribute their presence to venepuncture-488 associated contamination of the blood sample (and make recommendations to avoid 489 this in future), the presence of these viable organisms does not undermine our data 490
that support an abundance of bacteria-associated DNA and RNA within the blood, 491
likely present due to translocation. On reflecting upon our experimental approach, we 492 make the following recommendations for future studies; 493 494
(1) More attention should be paid to blood collection procedures as any 495 contamination occurring at this stage affects all downstream procedures. In addition 496
to alcohol cleansing of the skin (as performed in this study), we recommend that the 497 first volume drawn is diverted to a secondary tube, and analysed separately. This will 498 allow further investigation of venepuncture-associated contamination. 499 500
(2) The inclusion of negative control reactions that are subject to the whole range of 501 experimental procedures, including library preparation and sequencing, is absolutely 502 essential. 503 504
(3) Where possible, RNA-seq studies used for unmapped read assembly should 505
include negative control samples that are subject to all of the experimental 506
procedures alongside the study samples. This will allow an appraisal of how 507 significant reagent / laboratory procedure contamination is in these studies. Often the 508 use of RNA-seq derived unmapped reads for microbiome characterisation is a 509 "secondary use", and this is simply not possible. 510 511
(4) Seminal studies are still required to satisfactorily investigate the phenomenon of 512 bacterial translocation from well-characterised microbiome niches to the blood. 513 514 515 
